318010 — Pharmsville Co Balance Sheet
0.000.00%
- KR₩28bn
- -KR₩12bn
- KR₩17bn
- 90
- 42
- 42
- 64
Annual balance sheet for Pharmsville Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 36,297 | 41,735 | 42,835 | 39,546 | 37,676 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,028 | 2,487 | 2,106 | 1,279 | 1,328 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 43,927 | 48,682 | 47,798 | 43,627 | 41,234 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 15,867 | 15,663 | 15,219 | 14,847 | 14,329 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 69,037 | 74,307 | 74,835 | 71,279 | 67,140 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,822 | 7,240 | 6,933 | 5,449 | 2,165 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 13,382 | 15,107 | 12,273 | 7,365 | 2,618 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 55,655 | 59,200 | 62,562 | 63,914 | 64,522 |
| Total Liabilities & Shareholders' Equity | 69,037 | 74,307 | 74,835 | 71,279 | 67,140 |
| Total Common Shares Outstanding |